Navigation Links
MyMedLab Releases First Offer in Its Unique Personalized Medicine Series
Date:8/10/2009

The first program launched is with thyroid patient advocate and best selling author Mary Shomon

Joplin, MO (PRWEB) August 10, 2009 -- MyMedLab, Inc. today announced the first in a series of collaborations with best-selling authors and health leaders in their "Personalized Medicine" series. The author chosen to pilot the first release is nationally-known thyroid patient advocate and best-selling author Mary Shomon. The new program creates an offer that combines a copy of Mary Shomon's new book The Menopause Thyroid Solution, a custom MyMedLab test panel created by Shomon to complement her book, and a personal coaching consultation with Mary to discuss a plan of action.

"We are very excited to have Mary and her new book be a part of this next generation health care solution", says David Clymer, MyMedLab CEO. "There are a number of reasons why the author and the subject of thyroid health is a great fit for personalized medicine. Thyroid problems are not difficult to diagnose with the correct lab tests, but they continue to be among the most under-diagnosed and overlooked conditions for women in America," explains Clymer.

Individuals researching and advocating for their health frequently encounter a whole host of adversarial points of view. Doctors may
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. APA Releases Report on Sexuality Debate
2. ORTHOWORLD Releases Position Paper on Healthcare Reform
3. PracticeMatch Releases Results of Recent State of the Industry Survey of Physician Recruiters
4. Census Bureau Releases Comprehensive Health Insurance Coverage Estimates by County
5. Concord Coalition Releases Issue Brief on Administrations IMAC Proposal
6. Insurance Department Releases Report on Executive Compensation at States Largest Blues Plans
7. Photos: Compete Releases Top Insurance and Physician Web Sites for June 2009
8. NBCH Releases Report on Health Plans Performance for Cardiovascular Disease Care and Prevention
9. Integrated Healthcare Association Releases White Paper on Pay for Performance
10. Wonderbox Technologies(R) Releases Version 4.5 of the Enterprise System
11. Shelbourne Releases New Information on Knee Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 30, 2015 , ... Ross A. Clevens, MD, FACS has been ... of Plastic Surgery. This is Dr. Clevens’ second appointment by the prestigious school. ... developing a strong presence and a valuable mentoring program for medical students. ...
(Date:7/30/2015)... ... July 30, 2015 , ... Western University of Health Sciences ... Special Olympics World Games, the largest sports and humanitarian event in the world this ... , The World Games, held July 25 through August 2, 2015, benefited from the ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... ... 30, 2015 , ... New research finds some distinct differences in the way ... on the Surviving Mesothelioma website. , Researchers with the National Institutes of Health, ... cases of mesothelioma occurring between 1990 and 2010. Two percent of these cases (207) ...
(Date:7/30/2015)... ... 30, 2015 , ... Political unrest is the number one ... new survey by leading international insurance provider Clements Worldwide. The "Clements Worldwide Risk ... the largest sources of financial losses among respondents. , Twenty-eight percent of top ...
Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3
... blood sugar namely blindness, malfunction of the kidneys are known. ... have now come out with astonishing details that a raise ... than 100 adults with type 1 diabetes hwo had four ... mouth, having a sweet taste in their mouth and needing ...
... the globe as 95% of the AIDS victims dwell ... Special Session on HIV/AIDS, physicians demanded to bring down ... the AIDS victims in developing countries. ,Dr. Anne-Valerie ... as Medicines Sans Frontieres, or MSF), MSF provides healthcare ...
... Heart Association's 41st Annual Conference on Cardiovascular Disease Epidemiology ... new cousin counterpart to heart disease-Asthma. It is found ... ,Carlos Iribarren, MD, MPH, PhD, of Kaiser Permanente, in ... had a risk of 33% towards developing the heart ...
... number of psychological benefits, including fighting stress-related physical and ... found no psychological benefit from the use of ginseng. ... the sport and exercise psychology lab at the Oregon ... Engles, PhD, conducted the study and found that there ...
... the major cause of morbidity in most of the ... reluctant to take extra vitamins or iron pills, as ... were effective for improving the iron status of young ... iron deficiency in children of low-to-middle income groups. These ...
... is an inherited disease of the nervous system due ... causing symptoms such as involuntary movements and balance problems ... speech as well. ,All these days, until now, ... a mutated form of the protein 'huntingtin' which is ...
Cached Medicine News:Health News:Asthma! A new warning for heart disease 2
(Date:7/30/2015)... 30, 2015  NanoSmart Pharmaceuticals, Inc., a private ... received Orphan Drug Designation from the Food and ... that uses NanoSmart,s proprietary drug delivery platform. The ... the treatment of Ewing,s sarcoma, a rare type ... Orphan Drug Designation on the basis of a ...
(Date:7/30/2015)... July 30, 2015 /PRNewswire/ - Anything Technologies Media, Inc. ... Frontier Indoor Garden Solutions (FIGS), www.frontiergarden.com ... and the Project Manager for a My Compassion ... American Group located in Alaska.  The project will ... its finance Teaming Partners. The first phase of ...
(Date:7/30/2015)... 2015  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) ... webcast at 5:00 p.m. Eastern Time (2:00 p.m. Pacific ... quarter 2015 financial results and provide a corporate update. ... Global Select Market closes that day. The ... domestic callers and 914.495.8552 for international callers. Please specify ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 2Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 3Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5 4
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... Health Care Conference. Piper Jaffray Health Care Conference ... 2:00 p.m. ET A ... at http://www.avanir.com . About Avanir Pharmaceuticals, ...
... 2011  Cara Therapeutics, Inc. today announced the initiation ... an oral formulation of its peptide-based, kappa opioid ... trial is expected to enroll up to 60 ... evaluate the pharmacokinetic, pharmacodynamic and safety profile of ...
Cached Medicine Technology:Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist 2
Reptilase-Time from Bothrops atrox...
Pefakit PiCT UFH Controls...
Pefakit PiCT LMWH Calibrators...
APTT (Ellagic Acid) - 10 ml...
Medicine Products: